Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care

Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care

Thumbnail Image
Download
Name

Synthetic biology.pdf

Size

1.15 MB

Format

Adobe PDF

Checksum (MD5)

db1b699344b608eac0ff9c787c753a02

Author(s)
Cleto, Sara
•
Lee, Kevin
•
Perez-Pinera, Pablo
•
Han, Ningren
•
Cao, Jicong
•
Purcell, Oliver
•
Shah, Kartik A
•
Ram, Rajeev J
•
Lu, Timothy K
Date Issued
July 2016
Journal
Nature Communications
Publisher
Nature Publishing Group
Citation
Perez-Pinera, Pablo; Han, Ningren; Cleto, Sara; Cao, Jicong; Purcell, Oliver; Shah, Kartik A.; Lee, Kevin; Ram, Rajeev and Lu, Timothy K. “Synthetic Biology and Microbioreactor Platforms for Programmable Production of Biologics at the Point-of-Care.” Nature Communications 7 (July 2016): 12211. © 2017 Macmillan Publishers Limited, part of Springer Nature
Version
Final published version
Abstract
Current biopharmaceutical manufacturing systems are not compatible with portable or distributed production of biologics, as they typically require the development of single biologic-producing cell lines followed by their cultivation at very large scales. Therefore, it remains challenging to treat patients in short time frames, especially in remote locations with limited infrastructure. To overcome these barriers, we developed a platform using genetically engineered Pichia pastoris strains designed to secrete multiple proteins on programmable cues in an integrated, benchtop, millilitre-scale microfluidic device. We use this platform for rapid and switchable production of two biologics from a single yeast strain as specified by the operator. Our results demonstrate selectable and near-single-dose production of these biologics in <24 h with limited infrastructure requirements. We envision that combining this system with analytical, purification and polishing technologies could lead to a small-scale, portable and fully integrated personal biomanufacturing platform that could advance disease treatment at point-of-care.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Massachusetts Institute of Technology. Research Laboratory of Electronics
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution 4.0 International License
http://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/109076
DOI of Published Version
https://doi.org/10.1038/ncomms12211
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.